Most cortisol-producing adenomas with overt Cushing’s syndrome are associated with mutations in the cAMP/PKA pathway (PRKACA and GNAS), which are less frequency detected in patients with PACS or ACS (23–27). Here, PRKACA is linked to Cushing syndrome.